UA64801C2 - Состав с антисептическими, репаративными и болеутоляющими свойствами - Google Patents
Состав с антисептическими, репаративными и болеутоляющими свойствами Download PDFInfo
- Publication number
- UA64801C2 UA64801C2 UA2001010045A UA2001010045A UA64801C2 UA 64801 C2 UA64801 C2 UA 64801C2 UA 2001010045 A UA2001010045 A UA 2001010045A UA 2001010045 A UA2001010045 A UA 2001010045A UA 64801 C2 UA64801 C2 UA 64801C2
- Authority
- UA
- Ukraine
- Prior art keywords
- animals
- wound
- wounds
- reparative
- days
- Prior art date
Links
- 230000002421 anti-septic effect Effects 0.000 title abstract description 3
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 43
- 206010052428 Wound Diseases 0.000 abstract description 42
- 230000006378 damage Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000001356 surgical procedure Methods 0.000 abstract description 2
- 206010011985 Decubitus ulcer Diseases 0.000 abstract 1
- 206010051814 Eschar Diseases 0.000 abstract 1
- JQQZCIIDNVIQKO-UHFFFAOYSA-N benzyl-dimethyl-[3-(tetradecanoylamino)propyl]azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1 JQQZCIIDNVIQKO-UHFFFAOYSA-N 0.000 abstract 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract 1
- 231100000333 eschar Toxicity 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- GOZBHBFUQHMKQB-UHFFFAOYSA-N trimecaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=C(C)C=C1C GOZBHBFUQHMKQB-UHFFFAOYSA-N 0.000 abstract 1
- 229950002569 trimecaine Drugs 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 29
- 238000000034 method Methods 0.000 description 12
- 230000029663 wound healing Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 238000002266 amputation Methods 0.000 description 4
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 201000002818 limb ischemia Diseases 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008533 pain sensitivity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003685 thermal hair damage Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108010033104 M-81 Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Изобретение относится к медицине и ветеринарии, в частности к составу с антисептическими, репаративными и болеутоляющими свойствами на гидрофильной основе, содержащему мирамистин, кальция пантотенат (D-пантенол) и тримекаин. Состав может быть применен для лечения и профилактики гнойных осложнений ожоговых, травматических, послеоперационных ран, пролежней и трофических язв.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2000106896A RU2177314C2 (ru) | 2000-03-22 | 2000-03-22 | Состав с антисептическими, репаративными и болеутоляющими свойствами |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA64801C2 true UA64801C2 (ru) | 2004-03-15 |
Family
ID=20232148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2001010045A UA64801C2 (ru) | 2000-03-22 | 2001-03-20 | Состав с антисептическими, репаративными и болеутоляющими свойствами |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2177314C2 (ru) |
| UA (1) | UA64801C2 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007027118A1 (fr) * | 2005-08-29 | 2007-03-08 | Victor Stanislavovich Polyakov | Composition dermatologique |
| KR20090082155A (ko) * | 2008-01-24 | 2009-07-29 | 한국생명공학연구원 | 신규한 디아민 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 암 치료용 약학 조성물 |
| DE102008039254A1 (de) | 2008-08-20 | 2010-02-25 | Megainpharm Gmbh | Arzneimittel |
| WO2011100994A1 (de) * | 2010-02-19 | 2011-08-25 | Megainpharm Gmbh | Arzneimittel enthaltend myramistin |
| RU2427379C1 (ru) | 2010-09-20 | 2011-08-27 | Закрытое акционерное общество "Институт прикладной нанотехнологии" | Состав для профилактики и ухода за диабетической стопой |
| RU2733714C2 (ru) * | 2017-11-07 | 2020-10-06 | Общество с ограниченной ответственностью "Трейдсервис" | Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков |
-
2000
- 2000-03-22 RU RU2000106896A patent/RU2177314C2/ru active
-
2001
- 2001-03-20 UA UA2001010045A patent/UA64801C2/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2177314C2 (ru) | 2001-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Subrahmanyam | Honey dressing versus boiled potato peel in the treatment of burns: a prospective randomized study | |
| JP6495183B2 (ja) | 表面の創傷を処置するための組成物および方法 | |
| US5145679A (en) | Topical emollient for prevention and treatment of circulatory induced lesions | |
| JPH0533204B2 (ru) | ||
| Vachhrajani et al. | Science of wound healing and dressing materials | |
| US20030158165A1 (en) | Wound treatment solution and method for using same | |
| Margraf et al. | A trial of silver-zinc-allantoinate in the treatment of leg ulcers | |
| US20200405637A1 (en) | Oil-based wound care compositions and methods | |
| US20040147534A1 (en) | Topical composition and method for treating occlusive wounds | |
| US9999605B2 (en) | Preparation for treatment of a non-oral treatment site comprising an active chlorine compound and amino acids | |
| Sawada et al. | Treatment of dermal depth burn wounds with an antimicrobial agent-releasing silicone gel sheet | |
| UA64801C2 (ru) | Состав с антисептическими, репаративными и болеутоляющими свойствами | |
| CN1268357C (zh) | 一种治疗疖、疽、痈、疔毒及烧烫伤的药物组合物 | |
| HOLDER et al. | The use of urea in the treatment of infected wounds | |
| Knight | Medical management of pressure sores | |
| RU2522214C1 (ru) | Способ стимуляции заживления ран различного генеза природным антиоксидантом дигидрокверцетином | |
| RU2416425C1 (ru) | Масло противопролежневое | |
| RU2404745C2 (ru) | Гидрофильная фармацевтическая композиция для лечения ожогов (варианты) | |
| RU2209074C2 (ru) | Состав для лечения ожогов | |
| WO1993010795A1 (en) | Topical emollient for prevention and treatment of circulatory induced lesions | |
| RU2528905C1 (ru) | Способ лечения ран мягких тканей различной этиологии | |
| RU2195262C2 (ru) | Фармакологическое средство на основе гиалуроновой кислоты, обладающее антимикробным, ранозаживляющим и противовоспалительным действием | |
| Weinstein | Update on wound healing: a review of the literature | |
| US11565020B2 (en) | Powdered collagen wound care compositions | |
| Canter | Conservative management of wounds |